A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: LEE011 (ribociclib)|DRUG: letrozole
Sponsor: Novartis Pharmaceuticals